Influence of lovastatin calcium on serum ET-1, PAO, H-FABP, VEGF, S100β, inflammatory cytokines and nerve function patients with acute cerebral infarction
- VernacularTitle:阿托伐他汀钙对急性脑梗死患者血清ET－1、PAO、H－FABP、VEGF、S100β、炎症因子及神经功能的影响
- Author:
Wei LIU
;
Shengmin SHAO
;
Sheng LI
;
Jianxin XIAO
- Publication Type:Journal Article
- Keywords:
atorvastatin calcium;
acute cerebral infarction;
endothelin-1;
polyamine oxidase;
heart-type fatty acid binding protein;
vascular endothelial growth factor;
S100β;
inflammatory factors;
neurological function
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;(3):134-137
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of atorvastatin calcium on serum endothelin-1(ET-1), polyamine oxidase(PAO), heart-type fatty acid binding protein(H-FABP), vascular endothelial growth factor(VEGF), 100β, inflammatory cytokines and nerve function in patients with acute cerebral infarction.Methods According to the random number table, 113 patients were randomly divided into two groups (n=61) and control group (n=52).The control group received conventional treatment methods, and observation group received atorvastatin calcium on the basis of control group. The treatment course was two weeks.Serum ET-1, PAO, H-FABP, VEGF, S100β, inflammatory cytokines and NIHSS score were compared between two groups before treatment, 7d and 14d after treatment.Results The serum levels of ET-1, PAO, H-FABP after 7d, 14d treatment of observation group was significantly lower than that of control group, respectively (P<0.05).The VEGF level of observation group after 7 d, 14 d treatment of observation group was significantly higher than that of control group, respectively (P<0.05).The S100βlevel after 7 d, 14 d treatment of observation group was significantly lower than that of control group, respectively (P<0.05).The hs-CRP, IL-8, TNF-αlevels after 7 d, 14 d treatment of observation group was significantly lower than that of control group, respectively (P<0.05).NIHSS score after treatment of observation group was significantly lower than that of control group (P<0.05).Conclusion The atorvastatin calcium can improve neurological function in patients with brain injury through reducing serum ET-1, PAO, H-FABP and S100βlevels, promote angiogenesis through increasing VEGF expression, and alleviate inflammation and ischemia-reperfusion injury through reducing inflammatory cytokines, thereby promote neurological functional recovery.
